You searched for viral vector - Page 29 of 53

News and Trends 22 Jun 2016

World’s first CRISPR Clinical trial has just been Approved!

…1 Credit: Jinek et al. (2012) A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity. Science (doi: 10.1126/science.1225829) Figure 2 Credit: Yin et al. (2014) Non-viral vectors for gene-based therapy….

June 22, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 6 Nov 2017

Swiss Biotech Pulls Major Investors into €42M Series B for Cancer Vaccines

…about competitors, Nicosia and COO Marina Udier said they believe they stand alone in this approach but what differentiates them from would-be competitors is their vector strategy. “Our vectors have…

November 6, 2017 - 3 minutesmins - By Evelyn Warner

News and Trends 10 May 2017

Oxford Synbio Startup with Eyes on Therapeutics gets hold of CRISPR

…favour of Charpentier earlier this year. Oxford Genetics will apply CRISPR to its genome engineering services, cell lines and gene therapy viral vectors, as well as in the production of…

May 10, 2017 - 2 minutesmins - By Evelyn Warner

News and Trends 30 Mar 2022

BIO-Europe Spring 2022: The Highlights

…and viral vectors. Sharp pointed out that many pharma companies “don’t know which direction they’re going, so they need to build relationships early with the CDMO. It’s not easy to…

March 30, 2022 - 13 minutesmins - By Editorial Team

Best in Biotech 21 May 2024

Eight companies spearheading Philadelphia’s biotech industry

…delivery agents such as viral vectors or complex formulations. ASOs are short, synthetic strands of nucleic acids designed to specifically bind to the mRNA of a target gene. By binding…

May 21, 2024 - 10 minutesmins - By Jules Adam

News and Trends 17 Aug 2021

Sanofi’s Translate Bio Buyout Shows Growing Hunger for mRNA Technology

…pharma has not traditionally shown big interest in new vaccine technologies. Johnson & Johnson and AstraZeneca developed their Covid-19 vaccines with adenoviral vector technologies. Merck had been a long-term investor…

August 17, 2021 - 5 minutesmins - By Mark Zipkin

News and Trends 19 Nov 2016

Looking for outperforming cell lines ? CHOvolution is an all-in-one kit for GMP Bioproduction

…of BSE, commonly known as mad cow disease. In light of this, Celonic has spent the last 17 years gaining an extensive understanding of the development of expression vectors, cell…

November 19, 2016 - 4 minutesmins - By Dani Bancroft

In Depth 29 Apr 2024

Can Brazil make cell and gene therapy costs affordable for all?

…provide technology, materials, and training to Bio-Manguinhos – the Fiocruz arm in charge of manufacturing vaccines, diagnostics, and biologics – so that it can manufacture CAR-T cell therapies and lentiviral…

April 29, 2024 - 6 minutesmins - By Willow Shah-Neville

In Depth 12 Feb 2024

RNA editing set to take off: could DNA’s short-lived cousin overcome the limitations of CRISPR gene editing?

…nanoparticles or viral vectors. For example, leading RNA editing company Wave Life Sciences uses short RNA-editing oligonucleotides that are chemically modified with N-acetylgalactosamine (GalNAc) to aid delivery. The advantage of…

February 12, 2024 - 7 minutesmins - By Willow Shah-Neville

uniQure Freeline aruvant blood disorders

News and Trends 4 Dec 2018

Gene Therapies for Blood Disorders Marching Through the Clinic

…therapies use distinct viral vectors for the delivery. In an ongoing phase I/II trial, announced by the Swiss company Aruvant Sciences, the company’s gene therapy had positive effects in two…

December 4, 2018 - 3 minutesmins - By Jonathan Smith

News and Trends 20 Apr 2022

Valneva’s Covid-19 Vaccine Reaches UK Market with EU In Sights

…viral vector vaccine. Valneva’s candidate also shows fewer side effects than many approved vaccines. Valneva is now working on getting the vaccine approved for elderly people and as a booster…

April 20, 2022 - 4 minutesmins - By Jonathan Smith

News and Trends 12 Oct 2022

Ascidian Therapeutics launches with $50M to rewrite RNA

…“Ascidian is redefining the treatment of genetic diseases by editing exons at the RNA level. With RNA exon editing, we can address genes too large to package into a viral…

October 12, 2022 - 4 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: viral vector

World’s first CRISPR Clinical trial has just been Approved!

Swiss Biotech Pulls Major Investors into €42M Series B for Cancer Vaccines

Oxford Synbio Startup with Eyes on Therapeutics gets hold of CRISPR

BIO-Europe Spring 2022: The Highlights

Eight companies spearheading Philadelphia’s biotech industry

Sanofi’s Translate Bio Buyout Shows Growing Hunger for mRNA Technology

Looking for outperforming cell lines ? CHOvolution is an all-in-one kit for GMP Bioproduction

Can Brazil make cell and gene therapy costs affordable for all?

RNA editing set to take off: could DNA’s short-lived cousin overcome the limitations of CRISPR gene editing?

Gene Therapies for Blood Disorders Marching Through the Clinic

Valneva’s Covid-19 Vaccine Reaches UK Market with EU In Sights

Ascidian Therapeutics launches with $50M to rewrite RNA

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!